Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
33.58
+1.91 (6.03%)
At close: Apr 2, 2026, 4:00 PM EDT
33.08
-0.50 (-1.49%)
After-hours: Apr 2, 2026, 7:42 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.61 billion as of April 2, 2026. Its market cap has increased by 349.70% in one year.
Market Cap
1.61B
Enterprise Value
1.13B
1-Year Change
349.70%
Ranking
Category
Stock Price
$33.58
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.61B, an increase of 166.90%. That is a compound annual growth rate of 71.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.61B | 11.00% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 1.60B |
| Intellia Therapeutics | 1.57B |
| Nuvation Bio | 1.55B |
| Immunocore Holdings | 1.54B |
| MBX Biosciences | 1.53B |
| Damora Therapeutics | 1.51B |
| Ardelyx | 1.50B |
| Trevi Therapeutics | 1.49B |